Clinical Outcomes in Dialysis Patients: Prospects for Improvement with Aldosterone Receptor Antagonists.
about
Mineralocorticoid Receptor Antagonism for Cardiovascular Protection in End-Stage Renal Disease: New Data But the Controversy Continues.Mineralocorticoid Receptor Blockade in End-Stage Renal Disease.Dialysate Potassium, Dialysate Magnesium, and Hemodialysis Risk.Complete remission of hypertension in a hemodialysis patient after adrenalectomy for primary aldosteronism and renal transplantation.
P2860
Clinical Outcomes in Dialysis Patients: Prospects for Improvement with Aldosterone Receptor Antagonists.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Clinical Outcomes in Dialysis ...... osterone Receptor Antagonists.
@en
type
label
Clinical Outcomes in Dialysis ...... osterone Receptor Antagonists.
@en
prefLabel
Clinical Outcomes in Dialysis ...... osterone Receptor Antagonists.
@en
P2860
P356
P1433
P1476
Clinical Outcomes in Dialysis ...... osterone Receptor Antagonists.
@en
P2093
John P Middleton
Samantha Dias Suthar
P2860
P356
10.1111/SDI.12421
P577
2015-08-04T00:00:00Z